GEODE CAPITAL MANAGEMENT, LLC
Position in GLSI — Greenwich LifeSciences, Inc.
CIK 1214717
BOSTON, MA
Position in GLSI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,734,292
+$547,412 QoQ
Shares Held
155,466
+2.5% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,952,012 across 528 Biotechnology names. GLSI ranks #226 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in GLSI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,734,292 | 155,466 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,186,880 | 151,684 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,414,053 | 142,116 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,260,566 | 138,982 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,307,075 | 137,010 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,505,616 | 134,071 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,919,113 | 133,550 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,203,911 | 127,689 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,161,385 | 58,244 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $492,504 | 46,816 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $407,453 | 46,092 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $385,153 | 39,933 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $550,676 | 39,933 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $606,981 | 39,933 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $384,556 | 42,259 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $347,092 | 40,979 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,367,749 | 69,712 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,640,328 | 67,420 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,223,825 | 56,919 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,354,631 | 52,395 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $493,043 | 14,463 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $256,019 | 7,020 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||